Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,038 | -53,908 | -34,422 | -17,226 | -75,438 |
| Depreciation Amortization | 3,322 | 2,463 | 1,617 | 783 | 2,722 |
| Accounts receivable | 19,993 | 19,998 | 19,998 | 20,000 | -20,158 |
| Accounts payable and accrued liabilities | -1,057 | 104 | -2,152 | -1,060 | 1,493 |
| Other Working Capital | 12,087 | 16,145 | 15,483 | 14,279 | 3,754 |
| Other Operating Activity | -7,671 | -12,242 | -12,709 | -16,530 | 27,374 |
| Operating Cash Flow | $-57,364 | $-27,440 | $-12,185 | $246 | $-60,253 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 50,000 | 50,000 | 50,000 | 45,000 | 794 |
| PPE Investments | -3,336 | -3,307 | -2,785 | -1,797 | -12,528 |
| Investing Cash Flow | $46,664 | $46,693 | $47,215 | $43,203 | $-11,734 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 39,619 | 19,700 | 19,700 | 19,714 | N/A |
| Debt Repayment | -241 | -179 | -118 | -58 | -205 |
| Common Stock Issued | 103,782 | 12,628 | 12,331 | 12,037 | 61,557 |
| Other Financing Activity | -207 | 0 | 0 | 0 | 4,638 |
| Financing Cash Flow | $142,953 | $32,149 | $31,913 | $31,693 | $65,990 |
| Beginning Cash Position | 44,817 | 44,817 | 44,817 | 44,817 | 50,814 |
| End Cash Position | 177,070 | 96,219 | 111,760 | 119,959 | 44,817 |
| Net Cash Flow | $132,253 | $51,402 | $66,943 | $75,142 | $-5,997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,364 | -27,440 | -12,185 | 246 | -60,253 |
| Capital Expenditure | -3,336 | -3,307 | -2,785 | -1,797 | -12,638 |
| Free Cash Flow | -60,700 | -30,747 | -14,970 | -1,551 | -72,891 |